Clear Creek Bio, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19 (NCT05166876) | Clear Creek Bio, Inc. | 2022-02-01 |
| CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 (NCT04575038) | Clear Creek Bio, Inc. | 2020-11-19 |
| Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 (NCT04425252) | Clear Creek Bio, Inc. | 2020-08-19 |
| A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (NCT03760666) | Clear Creek Bio, Inc. | 2018-12-20 |
Track Clear Creek Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.